Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin;Avaliação dos efeitos adversos clínicos e alterações laboratoriais em pacientes com acne vulgar tratados com isotretinoína oral

Anais Brasileiros de Dermatologia

Volumn 85, Issue 3, 2010, Pages 331-336

  Brito, Maria De Fátima De Medeiros ^a   Sant'Anna, Iara Pessoa ^a,b   Galindo, Juliana Cordeiro Souza ^a   Rosendo, Lígia Helena Pessoa De Melo ^a   Dos Santos, Josemir Belo ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Acne vulgaris; Isotretinoin; Isotretinoin adverse effects

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; ISOTRETINOIN; TRIACYLGLYCEROL;

ACNE VULGARIS; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALOPECIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEPHARITIS; BONE PAIN; CHEILITIS; CHOLESTEROL BLOOD LEVEL; CONJUNCTIVITIS; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; FOLLICULITIS; FOLLOW UP; HEADACHE; HUMAN; IMPETIGO; LABORATORY TEST; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAIL DISEASE; PYOGENIC GRANULOMA; QUESTIONNAIRE; SIDE EFFECT; TACHYCARDIA; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; XERODERMA;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77955605558     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962010000300006     Document Type: Article

References (25)

1. Rook's Textbook of Dermatology. 7th ed. London, UK; 2004. [CD ROM].
2. Chivot M. Treatment of acne by isotretinoin (general course). Rev Prat. 2002;52:845-9. (Pubitemid 34429208)
3. Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoid drugs in dermatology. Drugs. 1997;53:358-88. (Pubitemid 27117359)
4. Chivot M. Retinoid therapy for acne. A comparative review. Am J Clin Dermatol. 2005;6:13-9. (Pubitemid 40289257)
5. Fitzpatrick's. Dermatology in General Medicine. 6th ed. v. 2. New York: McGraw Hill; 2003.
6. Sampaio SPA, Rivitti EA. Dermatologia. São Paulo: Artes Médicas; 2001.
7. Williams RE, Doherty VR, Perkins W, Aitchison TC, Mackie RM. Staphylococcus aureus and intranasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol. 1992;126:362-4.
8. Ling TC, Parkin G, Islam J, Seukeran DC, Cunliffe WJ. What is the cumulative effects or long-term, low-dose isotretinoin on the development of DISH? Br J Dermatol. 2001;144:630-2.
9. DiGiovanna JJ, Sollitto RB, Abangan DL, Steinberg SM, Reynolds JC. Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol. 1995;131:1263-7.
10. Leachman SA, Insogna KL, Katz L, Ellison A, Milstone LM. Bone densities in patients receiving isotretinoin for cystic acne. Arch Dermatol. 1999;135:961-5. (Pubitemid 29382435)
11. Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A, et al. Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin. Acta Derm Venereol. 2001;81:350-2. (Pubitemid 34015491)
12. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29-37.
13. Magin P, Pond D, Smith W. Isotretinoin, Depression and suicide: a review of evidence. Br J Gen Pract. 2005:55:134-8.
14. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch dermatol. 2001;137:1102-3.
15. Chu A, cunliffe WJ. The inter-relationship between isotretinoin/acne and depression. J Eur Acad Dermatol Venereol. 1999;12:263.
16. Safran AB, Haliqua B, Roth A, Saurat J-A. Ocular sideeffects of oral treatment with retinoids. In: Saurat J-A, ed. Retinoids: ten years on. Basel: S. Karger; 1991. p. 315.
17. RxList. com [homepage]. [cited 2004 Aug 12]. Available from: http://www.rxlist.com/cgi/generic/isotret-ad.htm.
18. Azulay RD, Azulay DR. Dermatologia. Rio de Janeiro: Guanabara Koogan; 2004.
19. Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology. 2002;204:232-5.
20. Kunynetz RA. A review of systemic retinoid therapy for acne and related conditions. Skin Therapy Lett. 2004;9:1-4. Erratum in: Skin Therapy Lett. 2005;10:9.
21. Tallab T, Joharji H, Jazei M, Bahamdan K, Ibrahim K, Karkashan. Isotretinoin therapy: any need for laboratory assessment? West Afr J Med. 2004;23:273-5.
22. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 2001;45:S150-S7.
23. Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? J Dermatolog Treat. 2001;12:9-12.
24. Exner JH, Dahod S, PochiPE. Pyogenic Granuloma like acne lesions during isotretinoin therapy. Arch Dermatol. 1983;119:808-11.
25. Hasdemir C, Sagcan A, Sekuri C, Iidizli M, Ulucan C, Ceylan C. Isotretinoin (13-cis-retinoic acid) associated atrial tachycardia. Pacing Clin Electrophysiol. 2005;28:348-9. (Pubitemid 40604056)